ARID1A and ovarian clear cell cancer: Using this system, we demonstrated that tumors with an HNF-1β+/p53+/ARID1A+ immunophenotype including OHGSeCa and ovarian clear cell carcinomas (OCCCa) were associated with the most unfavorable prognosis.